Company Filing History:
9 out of 207 
7 out of 2,198 
3 out of 344 Years Active: 1981-2000
Title: Innovations and Contributions of Fadia E Ali in Platelet Aggregation Inhibition
Introduction
Fadia E Ali is a noted inventor based in Cherry Hill, NJ, with a remarkable portfolio of 19 patents. His work primarily focuses on developing compounds that play a vital role in inhibiting platelet aggregation, which is crucial for advancing treatments in various medical applications.
Latest Patents
Among his latest innovations are patents related to vitronectin receptor antagonists and fibrinogen receptor antagonists. These inventions involve compounds that have been found effective in inhibiting platelet aggregation. The patents also encompass pharmaceutical compositions designed for this purpose and methods for achieving inhibition of platelet aggregation, showcasing his substantial contribution to the field.
Career Highlights
Fadia has made significant strides in his career by working with renowned organizations, including SmithKline Beckman Corporation and SmithKline Beecham Corporation. His tenure at these companies allowed him to hone his expertise and contribute to groundbreaking research in pharmacology and biochemistry.
Collaborations
Throughout his career, Fadia has collaborated with esteemed colleagues such as William F Huffman and James Martin Samanen. These partnerships have been instrumental in fostering an environment of innovation and creativity, leading to significant advancements in the understanding of platelet function and potential therapeutic approaches.
Conclusion
Fadia E Ali's contributions to the field of medical research through his extensive patent portfolio have significantly impacted the understanding and treatment of conditions involving platelet aggregation. His commitment to innovation, coupled with strategic collaborations, underscores the importance of teamwork in achieving remarkable breakthroughs in science and medicine.